Literature DB >> 9788273

Myelin protein zero and membrane adhesion.

L B Spiryda1.   

Abstract

Protein zero (P0) is a member of the immunoglobulin gene superfamily (IgCAM) that is expressed at high levels in myelinated vertebrates in central (fish and amphibia) and peripheral (all species) myelin. This glycoprotein is the major adhesive component of peripheral myelin, where it mediates self-adhesion of the Schwann cell plasma membrane. Although the expression of P0 is naturally limited to Schwann cells, the molecular mechanisms of P0-mediated adhesion can be considered general and "obligatory" because, when expressed in a variety of cell lines, P0 induces strong intercellular adhesion. Modeling studies, X-ray crystallographic analysis, and experimental site-directed mutagenesis have provided excellent working models for understanding how P0 mediates adhesion at the atomic level. These models remain to be experimentally tested. However, in humans, certain mutations in P0 produce dysmyelinating disease, possibly due to disruptions in the predicted P0 lattice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788273     DOI: 10.1002/(SICI)1097-4547(19981015)54:2<137::AID-JNR2>3.0.CO;2-F

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

Review 1.  Myelin P0: new knowledge and new roles.

Authors:  Joseph Eichberg
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

2.  Myelin protein zero is one of the components of the detergent-resistant membrane microdomain fraction prepared from rat pituitary.

Authors:  Katsutoshi Taguchi; Haruko Kumanogoh; Shun Nakamura; Seiji Miyata; Shohei Maekawa
Journal:  J Mol Histol       Date:  2007-02-21       Impact factor: 2.611

3.  A charcot-marie-tooth type 1B kindred associated with hemifacial spasm and trigeminal neuralgia.

Authors:  James B Caress; James A Lewis; Clark W Pinyan; Victoria H Lawson
Journal:  Muscle Nerve       Date:  2019-04-08       Impact factor: 3.217

4.  Median nerve motor conduction velocity is concordant with myelin protein zero gene mutation.

Authors:  Yi-Chung Lee; Bing-Wen Soong; Yo-Tsen Liu; Kon-Ping Lin; Ker-Pei Kao; Zin-An Wu
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

5.  Myelin structure and composition in zebrafish.

Authors:  Robin L Avila; Brian R Tevlin; Jonathan P B Lees; Hideyo Inouye; Daniel A Kirschner
Journal:  Neurochem Res       Date:  2006-09-02       Impact factor: 3.996

6.  Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus.

Authors:  J E Libbey; I J McCright; I Tsunoda; Y Wada; R S Fujinami
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

7.  Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation.

Authors:  M Donaghy; S M Sisodiya; R Kennett; B McDonald; N Haites; C Bell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

8.  Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies.

Authors:  Paola Mandich; Paola Fossa; Simona Capponi; Alessandro Geroldi; Massimo Acquaviva; Rossella Gulli; Paola Ciotti; Fiore Manganelli; Marina Grandis; Emilia Bellone
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

9.  Tissue distribution of quiescin Q6/sulfhydryl oxidase (QSOX) in developing mouse.

Authors:  Kelly F Portes; Cecília M Ikegami; Joselito Getz; Ana P Martins; Lucia de Noronha; Luciana F Zischler; Giseli Klassen; Anamaria A Camargo; Silvio M Zanata; Estela Bevilacqua; Lia S Nakao
Journal:  J Mol Histol       Date:  2007-11-23       Impact factor: 2.611

10.  Fabrication and Evaluation of a Xenogeneic Decellularized Nerve-Derived Material: Preclinical Studies of a New Strategy for Nerve Repair.

Authors:  Ting Li; Zhigang Sui; Akira Matsuno; Hirotomo Ten; Kenichi Oyama; Akihiro Ito; Hong Jiang; Xiaomin Ren; Rabia Javed; Lihua Zhang; Qiang Ao
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.